News for 'Drugs and Cosmetics Act'

Notice to ayurvedic drugs firm for misleading Covid claims

Notice to ayurvedic drugs firm for misleading Covid claims

Rediff.com20 Apr 2021

The company claimed that its product is "three times better than remdesivir and that 'AAYUDH Advance starts where vaccines stop'."

Gambhir's foundation illegally stocked Covid medicine, HC told

Gambhir's foundation illegally stocked Covid medicine, HC told

Rediff.com3 Jun 2021

The drug controller submitted that action will be taken without delay against the foundation, drug dealers as also in other such cases which would be brought to its notice.

Why govt's drive to promote generic drugs is flawed

Why govt's drive to promote generic drugs is flawed

Rediff.com15 Jun 2018

Experts believe the move will have little impact given limited production of generic drugs and authority of doctors in prescribing medicines.

Govt to withdraw UPA drug regulatory bill, draft new rules

Govt to withdraw UPA drug regulatory bill, draft new rules

Rediff.com22 Jun 2016

India is one of the largest manufacturers of pharmaceutical products in the world with the annual production valued at over Rs 2 lakh crore.

Maharashtra asks Snapdeal to stop selling prescription drugs

Maharashtra asks Snapdeal to stop selling prescription drugs

Rediff.com18 Apr 2015

Flipkart, Amazon, too, under radar

Govt now allows doorstep delivery of drugs

Govt now allows doorstep delivery of drugs

Rediff.com27 Mar 2020

Medicines that fall under Schedule H category (class of prescription drugs) would be provided against a valid prescription that can be submitted either physically or over e-mail. Narcotics, psychotropics and controlled substances, though, cannot be delivered.

Law must not be used as tool to harass accused: SC

Law must not be used as tool to harass accused: SC

Rediff.com19 Dec 2022

The apex court, which quashed the criminal proceedings pending at a Chennai court against two people, said law is meant to exist as a shield to protect the innocent rather than being used as a sword to threaten them.

Ban on 5 medicines of Ramdev's Divya Pharmacy revoked

Ban on 5 medicines of Ramdev's Divya Pharmacy revoked

Rediff.com13 Nov 2022

Amending the earlier order, the authority on Saturday issued a fresh one allowing the firm to continue the production of these medicines.

Medical devices to be treated as drugs from next fiscal

Medical devices to be treated as drugs from next fiscal

Rediff.com12 Feb 2020

The new regime aims to bring in ease of doing business, as the NITI Aayog has proposed to do away with the need to have manufacturing licences to register medical devices or to get a certificate of compliance.

Uttarakhand bans 5 medicines made by Ramdev's Patanjali

Uttarakhand bans 5 medicines made by Ramdev's Patanjali

Rediff.com11 Nov 2022

The notice says the company can restart manufacturing these products only after the authority approves their revised formulation sheets.

UP bans sale of halal-certified products, no restriction on exports

UP bans sale of halal-certified products, no restriction on exports

Rediff.com19 Nov 2023

In a statement, the state government alleged 'malicious attempts' to discourage the use of products lacking a halal certificate not only seek 'unfair financial benefits' but also form part of a 'pre-planned strategy to sow class hatred, create divisions in society, and weaken the country' by "anti-national elements".

US: Indian couple sentenced for using unapproved cancer drugs

US: Indian couple sentenced for using unapproved cancer drugs

Rediff.com14 Jun 2014

A United States court has sentenced an Indian oncologist and his wife for using unapproved chemotherapy medications at their cancer institute for three years.

HC seeks status report from govt on illegal sale of medicines online

HC seeks status report from govt on illegal sale of medicines online

Rediff.com15 Mar 2023

The petitioner's lawyer interjected the rules are being framed for the last 5-6 years but nothing concrete has been done yet.

Uzbek kids' death: Noida company loses manufacturing licence

Uzbek kids' death: Noida company loses manufacturing licence

Rediff.com23 Mar 2023

The manufacturing licence of Noida-based pharmaceutical firm Marion Biotech has been cancelled by the Uttar Pradesh authorities, according to officials.

Cough syrup deaths: DCGI bans use of propylene glycol supplied by Delhi firm

Cough syrup deaths: DCGI bans use of propylene glycol supplied by Delhi firm

Rediff.com11 Mar 2023

Maya Chemtech India Pvt Ltd supplied propylene glycol used in Marion Biotech's cough syrups that were found to be "not of standard quality", according to the regulator.

Two women among 12 held so far in 3 states on espionage charges

Two women among 12 held so far in 3 states on espionage charges

Rediff.com19 May 2025

While six of them have been held from Punjab, five were nabbed from neighbouring Haryana, and one from Uttar Pradesh.

3 employees of Noida pharma arrested in Uzbek cough syrup death case

3 employees of Noida pharma arrested in Uzbek cough syrup death case

Rediff.com3 Mar 2023

Three employees of a Noida-based pharmaceutical firm, whose cough syrup is alleged to have led to the death of 18 children in Uzbekistan last year, were arrested on charges of manufacturing and sale of adulterated drugs, officials said.

Patanjali didn't have permission for COVID-19 drug: Uttarakhand govt

Patanjali didn't have permission for COVID-19 drug: Uttarakhand govt

Rediff.com25 Jun 2020

State Ayurved Department's licence officer Y S Rawat said the notice is being issued to the firm to explain from where it got the permission to launch a 'corona kit' as a cure from the virus.

Beware of false ayurveda ads on TV

Beware of false ayurveda ads on TV

Rediff.com18 Jul 2017

Channels across the board from news to general entertainment, music and movies telecast half-hour to one-hour advertorials promoting these products, mainly during non-prime time hours

Drugs ban: Partial relief for Wockhardt, Glaxo & Griffon

Drugs ban: Partial relief for Wockhardt, Glaxo & Griffon

Rediff.com18 Mar 2016

The Delhi High Court on Friday stayed the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.

Prescriptions a must to buy ayurveda drugs online, says consumer body

Prescriptions a must to buy ayurveda drugs online, says consumer body

Rediff.com14 Jul 2022

The Central Consumer Protection Authority (CCPA) on Thursday directed e-commerce entities to sell specified ayurveda, siddha and unani drugs only after customers upload valid medical prescriptions from registered doctors on the platforms.

Licences of 14 Patanjali, Divya Pharma products suspended: U'khand to SC

Licences of 14 Patanjali, Divya Pharma products suspended: U'khand to SC

Rediff.com1 May 2024

In an affidavit filed in the top court, the SLA has given details of the steps taken by it against Patanjali and Divya Pharmacy.

Antibiotics to be sold only against prescription

Antibiotics to be sold only against prescription

Rediff.com11 Feb 2013

Health & family welfare ministry's proposal seeks to restrict sale of antibiotics to check self-medication.

Pharma units face heat

Pharma units face heat

Rediff.com8 Aug 2005

Pharmaceutical companies that have failed to meet the deadline -- which expired on July 1 -- to comply with Schedule M of the Drugs & Cosmetics Act will find the going tough in the days ahead.

Dr Reddy's files second NDA in US

Dr Reddy's files second NDA in US

Rediff.com27 Jun 2003

Are e-pharmacies illegal in India?

Are e-pharmacies illegal in India?

Rediff.com20 Aug 2020

The legal regime does not permit home delivery of medicines, tough owing to situation of COVID-19 pandemic and an emergency-like situation, the government allowed the home delivery of medicines but it was meant for only neighbourhood pharmacies, AIOCD said.

India probes eye drop linked to vision loss in US

India probes eye drop linked to vision loss in US

Rediff.com4 Feb 2023

A three-member team each from the Central Drugs Standard Control Organisation (CDSCO) and the State Drug Controller visited the plant in Tamil Nadu's Kancheepuram, 40 km from Chennai, on Friday after the company recalled the eye drop.

Repackaged drugs likely to be labelled 'new'

Repackaged drugs likely to be labelled 'new'

Rediff.com2 Jan 2014

Roadblocks ahead as these medicines could face new clinical tests, more scrutiny

Lockdown: Govt allows doorstep delivery of essential medicines

Lockdown: Govt allows doorstep delivery of essential medicines

Rediff.com27 Mar 2020

According to a notification issued by the health ministry, medical retailers will be allowed to provide drugs to people at their doorstep.

Why is Novartis likely to lose Tiamulin drug licence?

Why is Novartis likely to lose Tiamulin drug licence?

Rediff.com19 Mar 2014

Legal experts and official sources said the alleged submission of fake documents can also lead to criminal charges against Novartis.

Andhra govt gives nod for use of ayurvedic med for Covid treatment

Andhra govt gives nod for use of ayurvedic med for Covid treatment

Rediff.com31 May 2021

The Andhra Pradesh government on Monday gave the green signal for the use of the traditional medicine, touted as a miracle cure particularly for COVID-19 patients, being prepared by an Ayurvedic practitioner B Anandaiah in Krishnapatnam village in SPS Nellore district.

After Maggi, regulator now watches food supplements

After Maggi, regulator now watches food supplements

Rediff.com15 Jun 2015

The category is expected to cross Rs 38,400 crore by 2020.

WHO wrong in linking Gambia kids deaths to Indian cough syrups: DCGI

WHO wrong in linking Gambia kids deaths to Indian cough syrups: DCGI

Rediff.com16 Dec 2022

In the letter, Somani said the samples of four made-in-India cough syrups linked to the deaths of 66 children in Gambia which were tested in government laboratory here were found to be complying with specifications and not to have been contaminated with DEG or EG according to the test reports.

What is the future of e-pharmacies in India?

What is the future of e-pharmacies in India?

Rediff.com19 Dec 2019

PharmEasy, 1mg and Netmeds believe that their disruptive capabilities will power their brands despite the recent court ruling. The Drug Controller General of India recently directed all state FDAs to stop the online sale of medicines as per a Delhi high court order of last year.

FIR filed against Snapdeal CEO, directors

FIR filed against Snapdeal CEO, directors

Rediff.com1 May 2015

In April, Snapdeal had said it was delisting the drugs from its portal and was assisting the regulator in the investigation.

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Rediff.com22 Aug 2022

'Gift-giving' - from free dinners and drug samples to promotional merchandise - seems to be driving drugmakers' marketing - a marketing prescription deeply entrenched in the industry. This is a well-oiled racket that sees pharmaceutical (pharma) companies 'gifting' doctors to push their respective drugs under the guise of marketing. But is there a cure in sight to end this unhealthy alliance? The recent controversy following the income-tax raids on Bengaluru-based drugmaker Micro Labs, makers of popular paracetamol brand Dolo-650, has brought this to the fore, again.

Stop advertising Covid 'medicines', give details: Govt to Patanjali

Stop advertising Covid 'medicines', give details: Govt to Patanjali

Rediff.com24 Jun 2020

Ramdev's herbal medicine company Patanjali Ayurved has launched 'Coronil tablet and Swasari vati' medicines claiming they can cure the highly contagious disease within seven days.

Delhi HC sets aside government decision to cap condom prices

Delhi HC sets aside government decision to cap condom prices

Rediff.com11 Jul 2015

In a relief to pharma majors, the Delhi high court today held as "illegal and unsustainable" the Centre's decision to put a ceiling on the price of condoms, including the luxury variety.

Ranbaxy Lab dips nearly 7% on bourses

Ranbaxy Lab dips nearly 7% on bourses

Rediff.com24 Jun 2013

As per the media report, the US Food and Drug Administration is learnt to have issued a Form 483 to the company's manufacturing facility at Mohali a few months ago after finding deviations from norms during an inspection of the plant.